Blueberries Medical Corp (BBM)

0.0300 +0.0050 (+20.00%)
Closed CAD Disclaimer

Blueberries Medical Corp Company Profile

Equity Type
Blueberries Medical Corp. (Blueberries) is a Canada-based company, which is a licensed producer of psychoactive and non-psychoactive cannabis by-products in Colombia. The Company is engaged in the cultivation and development of medicinal cannabis and related products. The Company is specialized in agriculture, genetics, extraction, medicine, pharmacology and marketing. Blueberries are also licensed for the cultivation, production, domestic distribution, and international export of cannabidiol (CBD) and tetrahydrocannabinol (THC)-based medical cannabis. Its geographical segment includes Colombia, Canada and Panama. The Company’s subsidiaries include Blueberries Research Corporation (BRC), Blueberries SAS (BBSAS), Centro De Desarrollo e Investigacion (CDIBBSAS), BBV Labs Inc. (BBV Labs.) and SATIN S.A.S. (SATIN).
Contact Information
Bogotá, Colombia
57 3 161 70133
Top Executives
Joaquin Barbera 0 2021 Independent Director
Patricio Villalba 46 2019 Independent Director
Sebastian Hochbaum 0 2021 Director
Facundo Garreton 0 2021 Chairman & Interim CEO
Clear All
Please try another search

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.